Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-101 vs Ceftazidime in cUTI
NCT00921024Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ceftolozane in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Merck & Co.. Started Jun 2009; status: completed.
02
Drugs
ceftolozane
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT00921024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00921024.